In vivo, humanized mice engrafted with T cells expressing these optimized vectors had significantly higher CD4 T cell counts, greater CAR+ CD8 T cell proliferation after HIV infection, and 90% less HIV RNA, compared to mice that received T cells transduced with the clinical trial CD4-zeta CAR. Here, CD4 is linked to HIV infectious disease.